We present possibilities for drug repurposing (e.g. dalfampridine) and highlight processes of signal transduction and cell adhesion (negative regulation of protein binding, PTPRF, SEMA3F, KCNH3, KCNJ13) as potential novel avenues for ADHD treatment. Here, KCNH3 is linked to attention deficit-hyperactivity disorder.